Robeco Institutional Asset Management B.V. Lowers Stake in Baxter International Inc (BAX)

Share on StockTwits

Robeco Institutional Asset Management B.V. lowered its stake in shares of Baxter International Inc (NYSE:BAX) by 1.6% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 2,283,099 shares of the medical instruments supplier’s stock after selling 37,596 shares during the period. Baxter International accounts for 0.7% of Robeco Institutional Asset Management B.V.’s portfolio, making the stock its 22nd largest position. Robeco Institutional Asset Management B.V.’s holdings in Baxter International were worth $176,038,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Private Trust Co. NA raised its position in Baxter International by 6.3% in the 3rd quarter. Private Trust Co. NA now owns 11,572 shares of the medical instruments supplier’s stock worth $892,000 after purchasing an additional 690 shares during the period. BKD Wealth Advisors LLC raised its position in Baxter International by 1.8% in the 2nd quarter. BKD Wealth Advisors LLC now owns 41,331 shares of the medical instruments supplier’s stock worth $3,052,000 after purchasing an additional 732 shares during the period. FineMark National Bank & Trust raised its position in Baxter International by 6.0% in the 2nd quarter. FineMark National Bank & Trust now owns 13,239 shares of the medical instruments supplier’s stock worth $978,000 after purchasing an additional 753 shares during the period. Cpwm LLC raised its position in Baxter International by 22.8% in the 2nd quarter. Cpwm LLC now owns 4,230 shares of the medical instruments supplier’s stock worth $312,000 after purchasing an additional 784 shares during the period. Finally, Knowledge Leaders Capital LLC raised its position in Baxter International by 1.0% in the 2nd quarter. Knowledge Leaders Capital LLC now owns 79,384 shares of the medical instruments supplier’s stock worth $5,862,000 after purchasing an additional 786 shares during the period. Hedge funds and other institutional investors own 82.28% of the company’s stock.

A number of brokerages recently commented on BAX. Zacks Investment Research upgraded shares of Baxter International from a “hold” rating to a “buy” rating and set a $87.00 target price on the stock in a research report on Tuesday, September 25th. Argus restated a “hold” rating on shares of Baxter International in a research report on Tuesday, September 4th. JPMorgan Chase & Co. boosted their price objective on shares of Baxter International from $80.00 to $85.00 and gave the company an “overweight” rating in a research report on Friday, July 27th. Royal Bank of Canada restated a “hold” rating and issued a $76.00 price objective on shares of Baxter International in a research report on Friday, July 27th. Finally, Piper Jaffray Companies boosted their price objective on shares of Baxter International from $77.00 to $83.00 and gave the company an “overweight” rating in a research report on Friday, July 27th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and eleven have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $75.25.

Shares of BAX opened at $63.48 on Friday. The stock has a market cap of $33.79 billion, a PE ratio of 25.60, a P/E/G ratio of 1.71 and a beta of 1.02. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.00 and a current ratio of 2.60. Baxter International Inc has a 1-year low of $61.05 and a 1-year high of $78.38.

Baxter International (NYSE:BAX) last announced its earnings results on Wednesday, October 31st. The medical instruments supplier reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.06. The firm had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.79 billion. Baxter International had a net margin of 10.90% and a return on equity of 17.67%. The company’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.64 EPS. Research analysts expect that Baxter International Inc will post 3 EPS for the current year.

In other news, SVP Giuseppe Accogli sold 17,647 shares of Baxter International stock in a transaction dated Monday, September 17th. The shares were sold at an average price of $77.27, for a total transaction of $1,363,583.69. Following the sale, the senior vice president now owns 59,452 shares of the company’s stock, valued at approximately $4,593,856.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.05% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Robeco Institutional Asset Management B.V. Lowers Stake in Baxter International Inc (BAX)” was originally published by Week Herald and is the property of of Week Herald. If you are reading this news story on another site, it was stolen and republished in violation of US and international copyright & trademark laws. The correct version of this news story can be viewed at https://weekherald.com/2018/11/10/robeco-institutional-asset-management-b-v-lowers-stake-in-baxter-international-inc-bax.html.

Baxter International Profile

Baxter International Inc provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

Featured Story: What is dollar cost averaging (DCA)?

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc (NYSE:BAX).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply